Unlock instant, AI-driven research and patent intelligence for your innovation.

Synthetic method of perhexiline drug intermediate alpha-(2,2-diphenyl vinyl) pyridine

A technology of diphenylethylene and perhexiline, which is applied in the field of synthesis of α-pyridine, an intermediate of perhexiline, can solve problems such as myocardial ischemia aggravation, reduce intermediate links, reduce reaction temperature and reaction time , the effect of increasing the reaction yield

Inactive Publication Date: 2017-02-22
XIAMEN KAI ER LI INFORMATION TECH CO LTD
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Adverse reactions include prolonged ventricular ejection time and increased heart volume, which may aggravate myocardial ischemia or cause heart failure, but its effect on reducing myocardial oxygen consumption far outweighs its adverse reactions

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthetic method of perhexiline drug intermediate alpha-(2,2-diphenyl vinyl) pyridine

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0010] In a reaction vessel equipped with a stirrer, a reflux condenser, a thermometer, and a dropping funnel, add 1.56mol of 1,1-diphenyl-2-(α-pyridyl)ethylamine (2), with a mass fraction of 30% Phenyl hypochlorite solution (3) 1.81mol, nitromethane 300ml, control the stirring speed 150rpm, increase the solution temperature to 80°C, react for 3h, lower the solution temperature to 45°C, add a mass fraction of 20% potassium carbonate solution to adjust pH is 9, continue to stir for 5 hours, reduce the temperature of the solution to 10°C, precipitate solids, filter with suction, wash with ammonium nitrate solution, wash with 50% chlorobenzene, decolorize with molecular sieves, stir and reflux for 3 hours, dehydrate with anhydrous potassium carbonate, and Recrystallized in p-xylene with a mass fraction of 90%, to obtain 276.63 g of crystalline α-(2,2-diphenylvinyl)pyridine, with a yield of 69%.

example 2

[0012] In a reaction vessel equipped with a stirrer, a reflux condenser, a thermometer, and a dropping funnel, add 1.56mol of 1,1-diphenyl-2-(α-pyridyl)ethylamine (2), with a mass fraction of 32% Phenyl hypochlorite solution (3) 1.9mol, nitromethane 300ml, control the stirring speed at 170rpm, raise the solution temperature to 82°C, react for 4h, lower the solution temperature to 47°C, add a mass fraction of 23% potassium carbonate solution to adjust The pH is 9, continue to stir for 6 hours, reduce the temperature of the solution to 12°C, precipitate solids, filter with suction, wash with potassium iodide solution, wash with 52% chlorobenzene, decolorize with molecular sieves, stir and reflux for 3 hours, dehydrate activated alumina, Recrystallized from 92% p-xylene to obtain 292.67 g of crystalline α-(2,2-diphenylvinyl)pyridine with a yield of 73%.

example 3

[0014] In a reaction vessel equipped with a stirrer, a reflux condenser, a thermometer, and a dropping funnel, add 1.56mol of 1,1-diphenyl-2-(α-pyridyl)ethylamine (2), with a mass fraction of 35% Phenyl hypochlorite solution (3) 2.1mol, nitromethane 300ml, control the stirring speed at 190rpm, raise the solution temperature to 85°C, react for 5h, lower the solution temperature to 50°C, add a mass fraction of 25% potassium carbonate solution to adjust The pH is 10, continue to stir for 7 hours, lower the solution temperature to 15°C, precipitate solids, filter with suction, wash with ammonium nitrate solution, wash with 55% chlorobenzene, decolorize with molecular sieves, stir and reflux for 4 hours, dehydrate with anhydrous potassium carbonate, and Recrystallized in p-xylene with a mass fraction of 95%, to obtain 312.72 g of crystalline α-(2,2-diphenylvinyl)pyridine, with a yield of 78%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a synthetic method of perhexiline drug intermediate alpha-(2,2-diphenyl vinyl) pyridine. The synthetic method comprises the following steps: adding 1.56mol of 1,1-diphenyl-2-(alpha-pyridyl) ethylamine, 1.8-2.1mol of hypochlorous phenyl ester solution and 300ml of nitromethane into a reaction container which is provided with a stirrer, a reflux condenser, a thermometer and a dropping funnel; controlling stirring speed at 150-190rpm, raising the temperature of solution to 80-85DEG C, and reacting for 3-5h; lowering the temperature of the solution to 45-50DEG C, adding potassium carbonate solution to regulate pH (Potential Of Hydrogen) to be 9-10, and continuing stirring reaction for 5-7h; lowering the temperature of the solution to 10-15DEG C, carrying out precipitation to obtain a solid, carrying out suction filtration, washing by salt solution, washing by chlorobenzene, carrying out molecular sieve decoloring, and stirring and refluxing for 3-4h; dewatering by a dehydrating agent, and carrying out recrystallization in p-xylene to obtain crystal alpha-(2,2-diphenyl vinyl) pyridine.

Description

technical field [0001] The invention relates to a method for synthesizing a perhexiline drug intermediate α-(2,2-diphenylvinyl)pyridine. Background technique [0002] Perhexiline is a calcium antagonist, which can inhibit Ca2+ influx, relax vascular smooth muscle, significantly dilate coronary arteries, increase coronary blood flow, and has a better effect on angina pectoris. However, due to its many side effects (peripheral neuritis, increased intracranial pressure, liver dysfunction), it limits its use as the preferred antianginal drug. At the same time, this product can slow down the heart rate and reduce the left ventricular load, thereby reducing myocardial oxygen consumption. It has a good clinical effect in the treatment of angina pectoris. It is also effective for ventricular arrhythmia, but it is less effective for supraventricular arrhythmia; for patients who are ineffective with other antiarrhythmic drugs, this product is often effective. It can block the stimu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D213/38
CPCC07D213/38
Inventor 关艮安
Owner XIAMEN KAI ER LI INFORMATION TECH CO LTD